Genetic susceptibility to lung cancer and co-morbidities
J Thorac Dis. 2013 Oct;5 Suppl 5:S454-62. doi: 10.3978/j.issn.2072-1439.2013.08.06. Review.
Article predisposition génétique 2
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas
J Natl Cancer Inst. 2014 Jan;106(1):djt338. doi: 10.1093/jnci/djt338. Epub 2013 Dec 7.
Article HER2
ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer
J Thorac Oncol. 2009 Dec;4(12):1450-4. doi: 10.1097/JTO.0b013e3181c4dedb.
Article ALK
Cancer research. Looking for a target on every tumor.
Science. 2009 Oct 9;326(5950):218-20. doi: 10.1126/science.326_218.
Article Thérapies ciblées
The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo
Radiology. 1968 Apr;90(4):688-97.
Article princeps : Radiothérapie vs placebo dans le cancer bronchique inopérable
Early palliative care for patients with metastatic non-small-cell lung cancer
N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
Article princeps : amélioration de la survie avec des soins de support actifs
Article Radiothérapie stéréotaxique Baumann JCO 2009
J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4.
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
J Clin Oncol. 2008 Jul 20;26(21):3552-9. doi: 10.1200/JCO.2007.13.9030. Epub 2008 May 27.
Article princeps Chimiothérapie adjuvante des N1
Article Métanalyse chimiothérapie néo-adjuvante dans le cancer bronchique NPC
J Thorac Oncol. 2010 Apr;5(4):510-6. doi: 10.1097/JTO.0b013e3181cd3345.
Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.
Article phase II impact pronostique du downstaging médiastinal après chimiothérapie néo-adjuvante (Betticher 2003)
J Clin Oncol. 2003 May 1;21(9):1752-9.
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.